- Home
- GAME vs CRVO Comparison
GAME vs CRVO Comparison
Compare GAME & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GAME | CRVO |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 35.9M |
| IPO Year | 2024 | 2011 |
Fundamental Metrics
Financial Performance| Metric | GAME | CRVO |
|---|---|---|
| Price | $0.40 | $3.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | ★ 1.9M | 58.9K |
| Earning Date | 04-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.14 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $44,999,302.00 | $4,006,510.00 |
| Revenue This Year | $87.12 | N/A |
| Revenue Next Year | $21.14 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.24 | $2.82 |
| 52 Week High | $2.87 | $13.13 |
Technical Indicators
Market Signals| Indicator | GAME | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 46.30 | 35.30 |
| Support Level | $0.26 | $2.82 |
| Resistance Level | $0.49 | $4.27 |
| Average True Range (ATR) | 0.04 | 0.25 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 28.93 | 18.31 |
Price Performance
Historical ComparisonAbout GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is a vertically integrated digital media, entertainment, and technology company focused on gaming and youth culture audiences. The company operates through four reportable segments: Owned and Operated IP, Agency, SaaS and managed services, and Yield. It provides services including influencer marketing, esports talent management, creative production, merchandise and consumer products, live streaming analytics, and digital media solutions through its various brands and platforms. It generates the majority of its revenue from the Agency segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.